![]() |
![]() |
FOR THOSE SERVICES IDENTIFIED AS OUTSTANDING, AT LEAST 20% OF THEIR CAPACITY IS OPEN UNDER COMPETITIVE ACCESS. SEE ANNEX 1 OF ACCESS PROTOCOL FOR DETAILS ON % OF OPENNESS FOR EACH SERVICE
Title | Fundin: Organism | Call: Funding source | Role | ||
---|---|---|---|---|---|
GA: 720942 | ![]() | SMART FUNCTIONAL GLA-NANOFORMULATION FOR FABRY DISEASE – Smart-4-Fabry | Unión Europea (Comisión Europea) | H2020-NMBP-2016-2017 | Coordinator |
SAF2017-90810-REDI | ![]() | Strategic Promotion and coordinated management of Nanbiosis: Pronanbiosis II | Agencia Estatal de Investigación (AEI) | Acciones de dinamización «REDES DE EXCELENCIA» -ICTS 2017 | Coordinator |
Ref | Title | Funding Organism | Unit Role |
---|---|---|---|
PI15/00272 | Design of intelligent nanoconjugates for the treatment of metastatic colorectal cancer. | Instituto de Salud Carlos III | Participant |
H2020-MSCA-ITN-2014-642196 | Integrated self-assembled SWITCHable systems and materials: towards responsive organic electronics - a multi-site innovative training action i-Switch | Unión Europea H2020 | Participant |
2014 SGR 17 | Consolidation Research Group: Molecular Nanociènciai Materials Orgànics (NANOMOL) | Generalitat de Catalunya | Participant |
CTQ2013-40480-R | Molecular Bio- and Electro-active materials for the improvement of health and social well-being (Be-Well) | MICINN | Participant |
FP7-PEOPLE-2013-ITN nº 607721 | Nanochemistry of molecular materials for 2-photon functional applications. Nano2Fun | Unión Europea | Participant |
MAT2013-50036-EXP | Cell Surface Vessel Engineering Using Dynamic Molecular Bioinfecting (DYNAMO) | MINECO | Participant |
RTC-2016-4567-1 | Nanocapsules containing active ingredients for the topical treatment of dermatological diseases (NANO4DERM) | MINECO | Participant |
RTC-2014-2183-S | Application of Quatsomes technology for the development of a new range of perfumed softeners with lower environmental impact | MINECO | Participant |
201260E080 | Self-assembly, Nanostructuring and Processing of Functional Organic Molecules and their Applications | Ministerio de Ciencia e Innovación | Participant |
MAT2016-80826-R | Molecular materials and supramolecular organizations for therapy, diagnosis and tissue engineering (MOTHER) | MINECO | Participant |
RTC-2014-2207-1 | TERARMET: Development of therapies for the treatment of rare congenital metabolic diseases | MINECO | Participant |
26 Feb
28 February: International Rare Disease Day This is one of the major achievements of the European Smart4Fabry project, which is now coming to an end after four years of work.The results have been made possible by nanotechnology and the approach developed could be applied to other drugs in the future.The new drug improves on current treatments and helps reduce costs and improve patients’ quality of life. Barcelona, 26 February 2021.- The advance of nanomedicine opens up new possibilities in the development of drugs, such as the one recently developed for the rare disease Fabry, with improved efficacy compared to existing[...]
11 Feb
Today February 11 is the International Day of Women and Girls in Science, a day to raise awareness of the gender gap in science and technology. According to the United Nations, while yet women and girls continue to be excluded from participating fully in science, science and gender equality are vital to achieve the internationally agreed development goals, including the 2030 Agenda for Sustainable Development. Thus, in recent years, the international community has made a great effort to inspire and promote the participation of women and girls in science. NANBIOSIS wants to acknowledge the efforts made by scientific women who struggle every day to contribut[...]
27 Jan
Next Wedneday, February 3, 2021 will take place the on-line event Smart-4-Fabry Final Workshop. Smart-4-Fabry is a european project, coordinated by CIBER-BBN wich has been developed during four years. This project is a sign of cooperation at European level to boost nanomedicine development and translation to clinical stages. This project is also a clear example of the relevance of access to advanced research infrastructures as NANBIOSIS -ICTS. Four NANBIOSIS units have collaborated and contributed to Smart-4-Fabry development: U1 Protein Production Platform (PPP) at IBB-UABU3 Synthesis of Peptides Unit at IQAC-CSICU6 Biomaterial Processing and Nanostructuring Unit at ICMAB-CSICU20 In Vivo[...]
12 Dec
Judith Guasch, researcher from Nanomol group, coordinator of NANBIOSIS unit 6 of NANBIOSIS (CIBER-BBN / ICMAB-CSIC) is interviewed in Onda Cero Radio in the programme “De cero al infinito” con Paco de León, to talk about her recent research on hydrogels to mimic lymph nodes for cancer immunotherapy. You can listen the interview to Judith Guasch in this link, from minute 11: 33 to minute 29:35. In her interview, Judith Guasch explains her research on hydrogels to mimic lymph modes to grow more effectively T cells for cancer immunotherapy, about the patent, the costs of the cancer immunotherapy, and about the 3D bio-printing and scaling[...]
26 Nov
The U6 of NANBIOSIS (Biomaterial Processing and Nanostructuring Unit) has expanded its capabilities with 2 new equipment items for the characterization unit. Both equipment items will allow the characterization of some physico-chemical properties of different nanomaterials. The Zetasizer ULTRA is used to measure the particle size of dispersed systems from sub-nanometer to several micrometers in diameter, using the technique of Dynamic Light Scattering (DLS). Zetasizer systems are also used to analyze particle mobility and charge (Zeta potential) using the technique of Electrophoretic Light Scattering (ELS), and the molecular weight of particles in solution using Static Light Scattering (SLS). The Green[...]
12 Nov
The Soft Matrials Lab at ICMAB-CSIC, run by Amable Bernabé (NANBIOSIS U6 Biomaterial Processing and Nanostructuring Unit, hosted from Monday, 5 October, to Wednesday, 7 October a course on “Characterization techniques for particulate materials”. The course was an introduction to different techniques to characterize nanoparticles and other particulate matter, including the basic fundamentals, sample preparation, practical examples and results interpretation. Due to the COVID-19 pandemic, the participants of the course were less than in previous years, and during the practical sessions the group was divided, so less people was at the same time inside the lab, and the safety measures could be kept. Theory: Dynamic Light[...]
19 Oct
Guillem Vargas Nadal, researcher at Nanomol Group – NANBIOSIS U6 (ICMAB-CSIC and CIBER-BBN) and Nanomol Technologies will defend his PhD thesis on Friday, 23 October 2020, at 11 am in an online session. The PhD Thesis Defense will be held by videoconference from the ICMAB Meeting Room. Further information and Registration to attend the PhD Thesis defense via Zoom nanoparticles at ICMAB-website. Supervisors: Nora Ventosa (Scientific Director of NANBIOSIS U6 Biomaterial Processing and Nanostructuring Unit and leader of Nanomol Group of CIBER-BBNLidia Ferrer (Nanomol Technologies S.L.) Abstract: The nanovesicles are being developed and investigated to be used in the pharmaceutical world to deliver drug and detect[...]
09 Oct
ETPN2020, the 15th annual event of ETPN, European Technology Platform on Nanomedicine will take place, fully virtual on Oct. 14-15 to share the latest trends and success stories in Nanomedicine and emerging Medtech. In the frame of ETPN2020, on thursday Oct, 15, 12:00 will tak place the Workshop “Translational issues in nanomedicine” the workshop “Translational issues in nanomedicine” organized jointly by ETPN2020 and NMBP projects. Nora Ventosa, Scientific Director of NANBIOSIS U6 Biomaterial Processing and Nanostructuring Unit, will participate as coordinator of the european project Smart 4 Fabry The workshop chairs will be Fabrice Navarro (Head of Laboratory at CEA[...]